ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Gansu Longshenrongfa Pharmaceutical Industry (300534.SHE)
Gansu Longshenrongfa Pharmaceutical Industry stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Shenzhen Stock Exchange · China
CN¥9.68▼ -4.06%
Prices as of Oct 27, 2026 · CNY
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Gansu Longshenrongfa Pharmaceutical Industry in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Gansu Longshenrongfa Pharmaceutical Industry
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Gansu Longshenrongfa Pharmaceutical Industry a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CN¥8.23 and CN¥10.90; in 9 out of 10, between CN¥6.41 and CN¥13.99. Estimated annual volatility is 89%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- CN¥3.4B
- Market cap (USD)
- $512M
- P/E ratio
- 97.1
- Dividend yield
- 0.19%
- 52-week high
- CN¥20.96
- 52-week low
- CN¥6.78
- Revenue (12 months)
- CN¥738M
- Gross margin
- 66.3%
- Operating margin
- -1.7%
- Net margin
- 4.7%
- Beta
- 0.21
What this means
ATLAS does not publish a fair value for 300534.SHE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks 300534.SHE has traded between CN¥6.78 and CN¥20.96. Today it is 53.8% below that high and 43% above its low.
On the business: net margin is 4.7%; it trades at 97.1 times earnings.
Its beta is 0.21: it tends to move less than the market.
About the company
,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.
Want to see everything about Gansu Longshenrongfa Pharmaceutical Industry?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Gansu Longshenrongfa Pharmaceutical Industry do?
,LTD researches, develops, produces, and sells traditional Chinese medicines, medical devices, and health products in China and internationally.
What is the chance 300534.SHE goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, 300534.SHE ends the month between CN¥8.23 and CN¥10.90.
How big is Gansu Longshenrongfa Pharmaceutical Industry and what is its P/E ratio?
Gansu Longshenrongfa Pharmaceutical Industry's market capitalization is CN¥3.4B. Its price-to-earnings (P/E) ratio is 97.1: you pay CN¥97.1 for each CN¥1.00 of yearly earnings.
Does Gansu Longshenrongfa Pharmaceutical Industry pay a dividend?
Yes. 300534.SHE's current dividend yield is 0.19% at today's price (CN¥9.68).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer